CSPC Pharmaceutical Group Limited (01093) said its profit attributable to shareholders was RMB1.88 billion for the six months ended 30 June 2019, a year-on-year increase of 24.8%. The basic earnings per share were RMB30.13 cents. No dividend will be distributed.
The total revenue was RMB11.18 billion, a year-on-year increase of 27.6%. The gross profit was RMB7.81 billion, a year-on-year increase of 39.6%.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
